Navigation Links
Raptor Pharmaceuticals Corp. to Present at 2009 Cystinosis Research Network Family Conference
Date:7/16/2009

progress and enrollment criteria for our Phase 2b trial. We realize the effort necessary for patients to participate in clinical trials and extend our thanks to all who have participated in the studies that have brought DR Cysteamine to late-stage development. We are confident that DR Cysteamine has the potential to positively impact the long-term health of cystinosis patients, and our clinical team is working hard to make this option available to this entire patient population."

About Cystinosis Research Network

The Cystinosis Research Network is an all-volunteer, non-profit organization dedicated to supporting and advocating research, providing family assistance and educating the public and medical communities about cystinosis. The vision of the Cystinosis Research Network is the discovery of improved treatments and ultimately a cure for cystinosis. Its commitment to its community lies in its tireless efforts to provide family assistance through facilitating several support groups as well as hosting an annual conference. At this conference the Cystinosis Research Network brings families and the medical community together in hopes to accelerate the accomplishment of its stated goals and objectives.

About Raptor Pharmaceuticals Corp.

Raptor Pharmaceuticals Corp. ("Raptor") is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. Raptor focuses on underserved patient populations where it can have the greatest potential impact. Raptor currently has product candidates in clinical development to treat nephropathic cystinosis,

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
2. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.
3. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
4. The Glendale Raptors Set Dates for Youth Rugby League and USA Rugby Youth Academy
5. Glendale Raptors Join Four Points by Sheraton Denver Southeast and Animal Planets Dr. Kevin Fitzgerald for Second Annual Halloween Costume Drive & Halloween Party for Kunsberg School at National Jewish Medical and Research Center
6. Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
7. Smith & Nephew Endoscopys OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder
8. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
11. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... The Judicial Panel on Multidistrict Litigation (JPML) issued ... strokes, heart attacks, and other injuries in men who ... as the transferee judge and ordered what could be ... , As one of his first organizing acts, Judge ... who will move the litigation forward on behalf of ...
(Date:8/1/2014)... Barbara Bronson Gray HealthDay Reporter ... are obese and work in manufacturing jobs may have significantly less ... In a study of 32 people -- half were obese, half ... endurance times that were about 60 percent longer. Obesity also ... performance. Being older -- 50 to 65 years ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 As it ... behalf of women who allegedly experienced the spread of ... in gynecological surgeries, Bernstein Liebhard LLP notes the growing ... number of power morcellators marketed by its Ethicon, Inc. ... The New York Times, some critics of the company ...
(Date:8/1/2014)... and the benefits of a cancer diagnosis may improve ... a study conducted by a researcher at the University ... an expressive writing intervention is the writing instruction. Otherwise, ... events. Writing a journal can be therapeutic, but oftentimes ... it,s effective or not," said Qian Lu, assistant professor ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 On Monday, ... California NextGen User Symposium in San Francisco, CA. Now ... at the JW Marriott Union Square hotel. , “We ... get up to speed with ACA compliance issues,” Quirk ... month. The symposium provides attendees guidance with NextGen implementation ...
Breaking Medicine News(10 mins):Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2
... obstructive sleep apnea (OSA), a sleep disorder associated with ... coronary arteries, according to a study presented today at ... America (RSNA). "Our study reveals that individuals with ... form of atherosclerosis that puts them at risk for ...
... Using functional magnetic resonance imaging (fMRI), researchers have captured ... stimulus with and without acupuncture to determine acupuncture,s effect ... study, which the researchers say suggest the effectiveness of ... the Radiological Society of North America (RSNA). "Until ...
... Whitehead Institute researchers have shown in mouse models that ... leukemia and accelerate the disease,s progression. Their results are ... of the National Academy of Sciences (PNAS). "MicroRNAs ... mice, can upregulation of a microRNA actually cause the ...
... bottle of pomegranate juice at the store because you,ve learned ... replete with antioxidants that bring health benefits. But wait: ... is the product label you have carefully read promising more ... California, Riverside is determined to find out. Cynthia ...
... MONDAY, Nov. 29 (HealthDay News) -- Women have worse ... (PAD) in their lower extremities, a new study has ... for PAD surgery in lower extremities conducted from 1998 ... Of those hospitalizations, 162,730 (43.6 percent) were women. ...
... News) -- Patients who trust that their doctor would tell ... those who doubt their physician would own up to the ... doesn,t mean patients are less likely to sue. Researchers ... about 40 percent had personal experience with medical errors or ...
Cached Medicine News:Health News:People with sleep apnea at higher risk for aggressive heart disease 2Health News:Acupuncture changes brain's perception and processing of pain 2Health News:Tiny RNA shown to cause multiple types of leukemia 2Health News:Tiny RNA shown to cause multiple types of leukemia 3Health News:How authentic is your pomegranate juice? 2Health News:Peripheral Arterial Surgery Outcomes Worse for Women: Study 2Health News:Trust in Doctor May Affect Reaction to Medical Error 2
(Date:7/31/2014)... CHESTERBROOK, Pa. , July 31, 2014   ... a fully integrated specialty biopharmaceutical company, today announced that ... of 2014 on Thursday, August 7, 2014 before the ... will conduct a conference call that day at 8:30 ... second quarter of 2014. The presentation slides to be ...
(Date:7/31/2014)... -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ... of its lead molecule, Anatabine Citrate, in ... Clinical, The Translational Pharmaceutics Company, based in the ... early development programs. The Company expects to ... of the third quarter with the Medicines Healthcare products ...
(Date:7/31/2014)... , July 31, 2014  Decision Resources Group ... market intelligence product Marketrack to now include ChinaTrack; the ... device landscape in an interactive dashboard providing detailed brand-level ... volumes at a hospital level. Other key ... Updated data feed: In addition to end-user surveys of ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
... , HOPKINTON, Mass., Nov. 2 Caliper Life Sciences, Inc. ... tools, presented at a training session for reviewers from the ... of the LabChip GX platform for high throughput screening and ... accept the FDA,s invitation to present our LabChip platform to ...
... This week begins American Diabetes Month® - a ... the launch of a new campaign by the American Diabetes ... and one of its National Strategic Partners, Liberty Medical Supply, ... give diabetes patients practical tips and advice for living with ...
Cached Medicine Technology:Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration 2Educational Video Series Released for American Diabetes Month 2Educational Video Series Released for American Diabetes Month 3Educational Video Series Released for American Diabetes Month 4
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Peribulbar Needle, 25 g. Atkinson style bevel. Overall length 31 mm. 5/box....
Scleral Blade tip 5700 style, straight. Dimensions: 15.2 mm (L) x 3.4 mm (W). Cut: 2.7 mm....
Blade tip handle....
Medicine Products: